Cohen & Steers (US.CNS)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.CNS · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 102.9% | → |
| ROE | 15.6% | ↑ |
| Cash Conversion | -38.5% | ↑ |
| D/E Ratio | 0.23 | ↑ |
| Gross Margin | 52.4% | → |
US.CNS (Cohen & Steers) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY ---------------------------- FCF Conversion 102.9% → ROE 15.6% ↑ Cash Conversion -38.5% ↑ D/E Ratio 0.23 ↑ Gross Margin 52.4% →
Key Metrics
US.CNS (Cohen & Steers) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY----------------------------FCF Conversion 102.9% →ROE 15.6% ↑Cash Conversion -38.5% ↑D/E Ratio 0.23 ↑Gross Margin 52.4% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies